Dash Bio: Valuation, Funding & Investors
Dash Bio is a preclinical and clinical bioanalysis company that leverages a fully automated bioanalysis platform to enhance the speed, precision, and scalability of drug development. The company focuses on transforming the drug development process through innovative tech-enabled services, aiming to streamline and accelerate bioanalytical workflows.
Leadership & Board
Key Executives
- Founder
- Dave Johnson
- Founder
- Ander Tallett
- Founder
- Ely Porter
- Current Number of Employees
- 50
- Current LinkedIn Followers
- 8,462
Latest Estimated Valuation
- Total Amount Raised
- $48M
- Total Funding Rounds
- 3
- Latest Funding Amount
- $30M
- Latest Funding Round
- Series A
Company Momentum Positive
Dash Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Dash Bio had 50 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Dash Bio had 8,462 followers as of October 26, 2026. The number of followers increased by 59 (0.70%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 12, 2026 | Series A | $30.00M | ― |
| Aug 14, 2025 | Seed Round | $6.50M | ― |
| Jul 23, 2025 | Investment | $11.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Freestyle Capital | Seed Round |
| Swift Ventures | Seed Round |
| LifeX Ventures | Seed Round |
| Freestyle Capital | Investment |
| Swift Ventures | Investment |
| LifeX Ventures | Investment |
| The Aligned Fund | Investment |
| Cybernetix Ventures | Investment |
Similar Companies
A snapshot of private companies similar to Dash Bio, helping you discover and navigate related company profiles.
Related News and Analysis
